ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1935

Hypertrophic Pachymeningitis in a Population with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Study in a Single Japanese Institution

Yasuhiro Shimojima, Dai Kishida, Akiyo Hineno, Masahide Yazaki, Yoshiki Sekijima and Shu-ichi Ikeda, Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: ANCA and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Vasculitis - Poster II: ANCA-Associated Vasculitis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Hypertrophic pachymeningitis (HP) is an inflammatory disorder causing focal and diffuse thickening of the dura mater. It is realized that anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) contributes to the development of HP, whereas the epidemiologic and clinical characteristics of patients with HP in the whole population of AAV are still uncertain. In this study, we demonstrated the characteristics of patients with HP compared with those of patients without HP in AAV.

Methods: We retrospectively investigated the clinical records of 39 Japanese patients with AAV (18 men and 21 women). Among them, patients with associated HP were detected. To determine the characteristics of HP in AAV, the epidemiological and clinical data from patients with HP were statistically compared with those from patients without HP.

Results: Of 39 patients with AAV, 7 (17.9%) had associated HP. All patients with HP were classified as having granulomatosis with polyangiitis (GPA), whereas only 5 of 32 patients without HP were diagnosed as having GPA (P < 0.0001) (Table 1). The frequencies of myeloperoxidase (MPO)-ANCA and proteinase 3-ANCA positivity in patients with HP were equivalent, while MPO-ANCA positivity was obviously dominant in patients without HP. HP occurred as the initial clinical episode of AAV in 3 patients (7.7% of all AAV). Frequent significant characteristics of patients with HP were headache, cranial neuropathy, and paranasal involvement (P < 0.05), and histopathological findings from paranasal involvement were useful for the diagnosis of GPA in some patients with HP. Combination therapy of corticosteroid and an immunosuppressant, such as methotrexate, cyclophosphamide, or rituximab, was effective for achieving remission and improving radiographic findings of HP.

Conclusion: To our knowledge, this is the first study that has described the epidemiological analyses of HP in the whole population of AAV. We conclude that the epidemiological features of AAV patients with HP are different from those of patients without HP. The geographical studies of AAV indicated that the predominance of microscopic polyangiitis and MPO-ANCA positivity as epidemiologically specific to Japan, whereas GPA and PR3-ANCA positivity are dominant in European countries. However, the epidemiology of patients with HP is similar to that of patients in European countries. In addition, HP impacts the diagnosis of AAV because it could be an initial clinical sign of disease as well as associated with frequent existence of granulomatous lesions in the respiratory tract.


Disclosure: Y. Shimojima, None; D. Kishida, None; A. Hineno, None; M. Yazaki, None; Y. Sekijima, None; S. I. Ikeda, None.

To cite this abstract in AMA style:

Shimojima Y, Kishida D, Hineno A, Yazaki M, Sekijima Y, Ikeda SI. Hypertrophic Pachymeningitis in a Population with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Study in a Single Japanese Institution [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/hypertrophic-pachymeningitis-in-a-population-with-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-a-retrospective-study-in-a-single-japanese-institution/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hypertrophic-pachymeningitis-in-a-population-with-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-a-retrospective-study-in-a-single-japanese-institution/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology